Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03150641 · ClinicalTrials.gov registry record · NA
Delayed Cord Clamping at Term Cesarean
A NA study of Cesarean Delivery and Delayed Cord Clamping, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
- 1
- Study location
NCT03150641: Completed NA study of Cesarean Delivery and Delayed Cord Clamping, sponsored by Columbia University.
NCT03150641 is a NA study of Cesarean Delivery and Delayed Cord Clamping that has completed, run by Columbia University. The registered enrollment target is 113 participants, below the 3,472-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03150641, a NA study of Cesarean Delivery and Delayed Cord Clamping, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to find out how delaying cutting the umbilical cord until one minute after delivery of the baby during a cesarean impacts the amount of blood the mother loses during surgery. The study will also examine the benefits to the newborn from delayed cord clamping during cesarean.
Primary Outcome
Difference in hemoglobin between routine pre-op CBC and a postpartum CBC collected on postoperative day #1, by venipuncture
Conditions Studied
Interventions
- PROCEDURE Umbilical cord clamping
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2017-09-18 |
| Est. Completion | 2018-03-31 |
| Phase | NA |
What the finished NCT03150641 record still lists
NCT03150641 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 3,472-participant average among 10 other Cesarean Delivery trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Cesarean Delivery appearing as the primary indexed condition, and to 1 intervention - of which Umbilical cord clamping is the first listed.
NCT03150641 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03150641 about?
NCT03150641 is a clinical study titled "Delayed Cord Clamping at Term Cesarean". The purpose of this research study is to find out how delaying cutting the umbilical cord until one minute after delivery of the baby during a cesarean impacts the amount of blood the mother loses during surgery. The study will also examine the benefits to the newborn from delayed cord clamping duri...
What is the current status of trial NCT03150641?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2017-09-18. Estimated completion is 2018-03-31.
What conditions does trial NCT03150641 study?
This clinical trial studies the following conditions: Cesarean Delivery, Delayed Cord Clamping, Maternal Blood Loss, Neonatal Health.
What interventions are being tested in trial NCT03150641?
The interventions under investigation include: Umbilical cord clamping (PROCEDURE).
Who is sponsoring clinical trial NCT03150641?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03150641 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cesarean Delivery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03150641's enrollment target sits among peer trials
113 7th of 10 higher than 4 of 10 other Cesarean Delivery trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cesarean Delivery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-Operative Cesarean Section Cosmesis
RECRUITING · NA
-
Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin
RECRUITING · NA
-
IC-CS Risk: Patient Outcomes
ACTIVE NOT RECRUITING · NA
-
COMFORT Trial: Complex Obstetric Management With Focused Regional Transversus Abdominis Plane Block
RECRUITING · Phase 4
-
The Society for Obstetric Anesthesia and Perinatology Research Network General Anesthesia Registry
RECRUITING
-
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI